Veradigm Inc. (MDRX)

OTC Markets OTCPK • Currently up 0.01 (+0.21%) in today's trading session

1 member of Congress has disclosed 4 trades in Veradigm Inc. (MDRX) via STOCK Act filings. The most recent disclosure was a sale by Peter Welch on 11 October 2019. Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Veradigm Inc. is currently trading at $4.74, positioned at 54% of its 52-week range ($3.25 – $6.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$4.74
24h Change
+0.01 (+0.21%)
52 Week Range
$3.25–$6.00
View on NASDAQ

Veradigm Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for MDRX

Select to highlight on chart
4 transactions
Compliance: 50%
Peter Welch11 Oct 201914 Nov 2019SaleStock$1,001 - $15,000N/A
Peter Welch11 Oct 201912 Aug 2020SaleStock$1,001 - $15,000N/A
Peter Welch9 Jan 20197 Feb 2019PurchaseStock$1,001 - $15,000N/A
Peter Welch9 Jan 201912 Aug 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$823.68M

Volume

625

Beta

0.56

P/E Ratio

-26.94

Fundamentals

EPS

$-0.18

Div. Yield

-

Open

$4.00

Day Range

$4.00 – $4.88

Company Information

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
OTC · USD
Country
US
CEO
Donald D. Trigg
IPO Date
1999-07-26
Website
veradigm.com

Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across...

Earnings

Next Report

Q3 2026

6 Nov

EPS Est.

$0.08

Rev. Est.

$144.1M

Days Until

59

Recent Quarters

Q2 202631 Aug
EPS-
Q2 202628 Aug
EPS-
Q1 202626 May
EPS$0.22
Beat 33.3%
Q4 202527 Feb
EPS$0.09
Beat 21.4%
Q3 20257 Nov
EPS$0.05
Beat 0.0%
Q2 20258 Aug
EPS$0.07
Beat 0.0%
Q4 202418 Mar
EPS$0.06
Miss 21.4%
Q4 202428 Feb
EPS$0.19
Miss 38.1%
Q3 20241 Nov
EPS$0.27
Beat 32.3%
Q2 20242 Aug
EPS$0.22
Beat 33.3%
Q4 202319 Mar
EPS$0.14
Miss 84.1%
Q4 20234 Jan
EPS$0.32
Beat 45.5%
Q3 202314 Dec
EPS$0.23
Beat 4.5%
Q2 202314 Sept
EPS$0.20
Miss 23.9%
Q1 202315 Jun
EPS$0.56
Beat 213.9%
Q4 20221 Mar
EPS$0.72
Beat 166.7%
Q3 20223 Nov
EPS$0.23
Beat 21.1%
Q2 20224 Aug
EPS$0.18
Beat 20.0%
Q1 20225 May
EPS$0.13
Miss 38.1%
Q4 202124 Feb
EPS$0.79
Beat 146.9%
Q3 20214 Nov
EPS$0.27
Beat 50.0%
Q2 20215 Aug
EPS$0.23
Beat 35.3%
Q1 202129 Apr
EPS$0.19
Beat 26.7%
Q4 202025 Feb
EPS$0.29
Beat 38.1%
Q3 202029 Oct
EPS$0.20
Beat 5.3%
Q2 202030 Jul
EPS$0.18
Beat 50.0%
Q1 20207 May
EPS$0.09
Miss 40.0%
Q4 20192 Mar
EPS$0.17
Miss 5.6%
Q3 20194 Nov
EPS$0.17
Beat 0.0%
Q2 20198 Aug
EPS$0.17
Beat 6.3%
Q1 20192 May
EPS$0.16
Beat 14.3%
Q4 201821 Feb
EPS$0.20
Miss 4.8%
Q3 20181 Nov
EPS$0.18
Miss 10.0%
Q2 20182 Aug
EPS$0.18
Beat 0.0%
Q1 20183 May
EPS$0.16
Miss 5.9%
Q4 201715 Feb
EPS$0.18
Beat 0.0%
Q3 20172 Nov
EPS$0.16
Beat 0.0%
Q2 20173 Aug
EPS$0.15
Beat 0.0%
Q1 20174 May
EPS$0.13
Beat 0.0%
Q4 201616 Feb
EPS$0.14
Miss 6.7%
Q3 20163 Nov
EPS$0.14
Miss 6.7%
Q2 20164 Aug
EPS$0.14
Beat 0.0%
Q1 20165 May
EPS$0.13
Beat 8.3%
Q4 201518 Feb
EPS$0.13
Beat 0.0%
Q3 20155 Nov
EPS$0.13
Beat 8.3%
Q2 20154 Aug
EPS$0.12
Beat 9.1%
Q1 20157 May
EPS$0.08
Miss 11.1%
Q4 201426 Feb
EPS$0.09
Beat 0.0%
Q3 20146 Nov
EPS$0.06
Miss 40.0%
Q2 20147 Aug
EPS$0.09
Beat 0.0%
Q1 20148 May
EPS$0.07
Beat 0.0%
Q4 201320 Feb
EPS$0.08
Beat 0.0%
Q3 20137 Nov
EPS$0.05
Miss 37.5%
Q2 20138 Aug
EPS$0.05
Miss 50.0%
Q1 20139 May
EPS$0.09
Miss 35.7%
Q4 201219 Feb
EPS$0.16
Miss 20.0%
Q3 20128 Nov
EPS$0.23
Beat 4.5%
Q2 20128 Aug
EPS$0.16
Miss 11.1%
Q1 201226 Apr
EPS$0.12
Miss 50.0%
Q4 201116 Feb
EPS$0.25
Beat 0.0%
Q3 20113 Nov
EPS$0.25
Beat 13.6%
Q2 20112 Aug
EPS$0.22
Beat 4.8%
Q1 20115 May
EPS$0.21
Beat 5.0%
Q4 201015 Feb
EPS$0.20
Beat 11.1%
Q3 20108 Nov
EPS$0.19
Beat 11.8%
Q2 201020 Jul
EPS$0.18
Beat 5.9%
Q1 20107 Apr
EPS$0.17
Beat 6.3%
Q4 200910 Jan
EPS$0.16
Beat 6.7%
Q2 200929 Sept
EPS$0.15
Beat 7.1%
Q2 200920 Jul
EPS$0.16
Beat 6.7%
Q1 20092 Apr
EPS$0.15
Beat 15.4%
Q4 20088 Jan
EPS$0.11
Miss 8.3%
Q3 200823 Oct
EPS$0.15
Miss 6.3%
Q2 20085 Aug
EPS$0.13
Beat 18.2%
Q1 200830 Apr
EPS$0.09
Miss 18.2%
Q4 200713 Feb
EPS$0.14
Beat 0.0%
Q3 20078 Nov
EPS$0.11
Miss 26.7%
Q2 20077 Aug
EPS$0.13
Miss 7.1%
Q1 20078 May
EPS$0.11
Miss 8.3%
Q4 200613 Feb
EPS$0.21
Beat 0.0%
Q3 200626 Oct
EPS$0.19
Beat 0.0%
Q2 20061 Aug
EPS$0.18
Beat 12.5%
Q1 20062 May
EPS$0.13
Beat 62.5%
Q4 200531 Jan
EPS$0.09
Beat 0.0%
Q3 200526 Oct
EPS$0.07
Beat 16.7%
Q2 200526 Jul
EPS$0.05
Beat 0.0%
Q1 200526 Apr
EPS$0.03
Beat 0.0%
Q4 200417 Feb
EPS$0.03
Beat 0.0%
Q3 200426 Oct
EPS$0.02
Beat 0.0%
Q2 200427 Jul
EPS$0.02
Beat 100.0%
Q1 20045 May
EPS$0.01
Q4 200319 Feb
EPS$0.00
Q3 200323 Oct
EPS$-0.02
Beat 33.3%
Q2 200316 Jul
EPS$-0.05
Miss 150.0%
Q1 200324 Apr
EPS$-0.05
Beat 0.0%
Q4 20026 Feb
EPS$-0.05
Beat 0.0%
Q3 200231 Dec
EPS$-0.08
Miss 60.0%
Q3 200224 Oct
EPS$-0.08
Beat 33.3%
Q1 200224 Apr
EPS$-0.16
Beat 5.9%
Q4 200112 Feb
EPS$-0.22
Beat 12.0%
Q3 200125 Oct
EPS$-0.31
Beat 0.0%
Q2 200124 Jul
EPS$-0.25
Miss 4.2%
Q1 200126 Apr
EPS$-0.28
Miss 16.7%
Q4 200027 Feb
EPS$-0.14
Beat 6.7%
Q3 200026 Oct
EPS$-0.19
Beat 13.6%
Q2 200027 Jul
EPS$-0.15
Beat 37.5%
Q1 200028 Apr
EPS$-0.22
Beat 18.5%
Q4 19997 Feb
EPS$-0.21
Beat 8.7%
Q3 199925 Oct
EPS$-0.27
Beat 3.6%
Q4 199831 Mar
EPS$0.07

2 politicians traded within 30 days

Dividends

Dividend History

13 Oct 2008
Amount $5.2300

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about MDRX

Which members of Congress have traded MDRX?
1 member of Congress has disclosed 4 trade in Veradigm Inc. (MDRX) under the STOCK Act: Peter Welch.
When was MDRX most recently disclosed by Congress?
The most recent MDRX disclosure was a sale by Peter Welch on 11 October 2019.
What is the total disclosed congressional trading volume for MDRX?
Members of Congress have disclosed approximately $16K in MDRX purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in MDRX?
This MDRX page updates as soon as new STOCK Act disclosures are filed for Veradigm Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.